BONEFOS

This brand name is authorized in Brazil, Finland, Hong Kong, Netherlands, Tunisia

Active ingredients

The drug BONEFOS contains one active pharmaceutical ingredient (API):

1 Clodronic acid UNII 0813BZ6866 - CLODRONIC ACID

Clodronic acid is a bisphosphonate, (formerly diphosphonates), a group of analogues of pyrophosphate, which have been shown, in vitro, to inhibit the formation and dissolution of calcium phosphate (hydroxyapatite). In vivo, they have been shown to inhibit bone resorption to a greater or lesser extent, depending on the compound, and clodronate is one of the most effective in this respect. Read about Clodronic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BONEFOS Film-coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BA02	Clodronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538900801114317, 538900802153316
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 081430, 107243
Country: HK	Department of Health Drug Office	Identifier(s): 35885
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 48194
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7243011